Craig-Hallum Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $16

Benzinga · 19h ago
Craig-Hallum analyst Adam Vogel initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $16.